BRCA1 and prostate carcinoma: For example, on the basis of the prostate cancer PRS, 43% of men with BRCA1 mutations are predicted to have a prostate cancer risk of greater than 17% and may benefit from enhanced screening, whereas those at lower risk may opt for more limited surveillance.